Global venture boss keeps an eye on Danish biotech companies
Omega Funds receives 2200 applications from life science companies per year and 99.9 percent of these are turned down. But some Danish biotech companies have caught the attention of founder Otello Stampacchia and might be among the 0.1 lucky ones.
BY LEONORA BECK
The Danish biotech field has received international attention over the last couple of years. Especially from the US, even though the country harbors many companies, hungry for capital, and two of the world’s leading biotech clusters.
Det har været et privilegium at stå i spidsen for Ambu, siger den nu fyrede topchef, Juan Jose Gonzalez, der takker sine medarbejdere for alt, hvad de har gjort i de godt tre år, han nåede at sidde på posten.